ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
12
views
0
references
Top references
cited by
5
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
835
similar
All similar
Record
: found
Abstract
: not found
Book
: not found
Textbook of Hemophilia : Lee/Textbook of Hemophilia
edited_book
Editor(s):
Christine A. Lee
,
Erik E. Berntorp
,
W. Keith Hoots
Publication date
(Online):
August 13 2010
Publisher:
Wiley-Blackwell
Read this book at
Publisher
Buy book
Review
Review book
Invite someone to review
Bookmark
Cite as...
There is no author summary for this book yet. Authors can add summaries to their books on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Amsterdam University Press
Author and book information
Book
ISBN (Electronic):
9781444318555
ISBN (Print):
9781405169141
Publication date (Print):
June 26 2010
Publication date (Online):
August 13 2010
DOI:
10.1002/9781444318555
SO-VID:
c144441c-78dc-4338-91ce-0aa2ceee7f7a
History
Data availability:
Comments
Comment on this book
Sign in to comment
Book chapters
pp. c1
Color Plates
pp. i
Front Matter
pp. 1
Historical Introduction
pp. 7
Overview of Hemostasis
pp. 13
Cellular Processing of Factor VIII and Factor IX
pp. 24
Molecular Basis of Hemophilia A
pp. 33
Phenotypic-Genotypic Relationship
pp. 38
Prophylaxis
pp. 44
Continuous Infusion of Coagulation Products in Hemophilia
pp. 52
Inhibitors to Factor VIII-Immunology
pp. 57
Genetic and Environmental Risk Factors for Inhibitor Development
pp. 62
Inhibitors to Factor VIII: Mild and Moderate Hemophilia
pp. 66
Inhibitors to Factor VIII/IX: Immune Tolerance
pp. 75
Inhibitors to Factor VIII: Treatment of Acute Bleeds
pp. 81
Acquired Inhibitors to Factor VIII
pp. 88
Hemophilia B-Molecular Basis
pp. 94
Factor IX Inhibitors in Hemophilia B
pp. 97
Treatment of Inhibitors in Hemophilia B
pp. 104
Pharmacokinetics
pp. 111
The Neonate with Hemophilia
pp. 118
Work-up of a Bleeding Child
pp. 127
Care of the Child with Hemophilia
pp. 133
Adolescence
pp. 138
Hemophilia and Medicine in Old Age
pp. 146
Products used to Treat Hemophilia: Recombinant Products
pp. 153
Plasma-Derived Coagulation Factor Concentrates
pp. 159
Products used to Treat Hemophilia: Recombinant Factor VIIa
pp. 165
Products used to Treat Hemophilia: Dosing
pp. 170
Products used to Treat Hemophilia: Regulation
pp. 176
Joint Replacement
pp. 182
Synoviorthesis in Hemophilia
pp. 187
Pseudotumors in Patients with Hemophilia
pp. 191
Imaging Modalities for Assessment of Hemophilic Arthropathy
pp. 200
Physiotherapy in the Management of Hemophilia
pp. 207
Clinimetric Instruments in Hemophilia
pp. 215
Hepatitis and Hemophilia
pp. 222
Transfusion-Transmitted Disease: Emerging Infections
pp. 226
Hemophilia Gene Therapy: An Overview
pp. 231
Gene Therapy Trials in Hemophilia A and B
pp. 239
Gene Therapy: Molecular Engineering of Factor VIII and Factor IX
pp. 247
Laboratory Assays in Hemophilia
pp. 254
Standardization of Assays in Hemophilia
pp. 263
Global Laboratory Assays in Hemophilia
pp. 269
Obstetrics and Gynecology: Hemophilia
pp. 278
von Willebrand Disease: Molecular Aspects
pp. 286
von Willebrand Disease: Epidemiology
pp. 294
von Willebrand Disease: Biologic Diagnosis
pp. 302
Classification and Clinical Aspects of Von Willebrand Disease
pp. 309
Women and Von Willebrand Disease
pp. 316
Treatment of Von Willebrand Disease: Desmopressin
pp. 320
Treatment of Von Willebrand Disease: Therapeutic Concentrates
pp. 328
Factor II
pp. 332
Factor V and Combined Factor V and VIII Deficiencies
pp. 341
Congenital Factor VII Deficiency
pp. 348
Factor X and Factor X Deficiency
pp. 355
Factor XI Deficiency
pp. 362
Factor XIII Deficiency
pp. 369
Fibrinogen
pp. 376
Miscellaneous Bleeding Disorders
pp. 394
Emergency Management of Hemophilia
pp. 401
Quality of Life in Hemophilia
pp. 409
The Economics of Hemophilia Treatment
pp. 415
National Hemophilia Databases
pp. 420
Comprehensive Care and Delivery of Care: The Developed World
pp. 429
Comprehensive Care and Delivery of Care in Hemophilia: The Developing World
pp. 435
Comprehensive Care and Delivery of Care: The Global Perspective
pp. 443
Index
Similar content
835
Kovats and lee retention indices determined by gas chromatography/mass spectrometry for organic compounds of environmental interest
Authors:
W. Pereira
,
C. E. Rostad
Figure 10 from: Lee C-F, Bezděk J (2020) Revision of the Theopea genus group (Coleoptera, Chrysomelidae, Galerucinae), part III: Descriptions of two new genera and nine new species. ZooKeys 912: 65-124. https://doi.org/10.3897/zookeys.912.47719
Authors:
Chi-Feng Lee
,
Jan Bezděk
Protein-nutritive assessment of sake lees obtained by brewing from liquefied rice.
Authors:
N Tsutsui
,
Y. Yamamoto
,
K Iwami
See all similar
Cited by
5
A cross-sectional study of bleeding phenotype in haemophilia A carriers
Authors:
Dave Gailani
,
Michael DeBaun
,
Robert Sidonio
…
Clinical and functional evaluation of the joint status of hemophiliac adults at a Brazilian blood center
Authors:
Adriana Ferreira
,
Maria Teresa Bustamante-Teixeira
,
Isabel Leite
…
Methods for anti‐factor VIII antibody levels in haemophilia A patients – validation of a multiplex immunoassay and comparability with assays measuring non‐neutralising and neutralising antibodies (inhibitors)
Authors:
Myriam Martin
,
Cecilia Augustsson
,
Vivian Lind
…
See all cited by